参考文献/References:
[1] Lin L, Wang J, Jiang Y, et al. Interstitial 125I seed implantation for cervical lymphnode recurrence after multimodal treatment of thoracicesophageal squamous cell carcinoma[J]. Technol Cancer Res Treat, 2015, 14: 201- 207.
[2] Gao F, Li C, Gu Y, et al. CT- guided 125I brachytherapy for mediastinal metastatic lymph nodes recurrence from esophageal carcinoma: effectiveness and safety in 16 patients[J]. Eur J Radiol, 2013, 82: e70- e75.
[3] Lü J, Cao XF. Dosimetry for 125I radioactive seed implantation therapy for hepatocellular carcinoma[J]. J Nanjing Med Univ, 2008, 22: 269- 272.
[4] 赵 鹏, 崔红凯, 杨瑞民, 等. 放射性125I粒子支架治疗中、晚期食管癌的疗效观察[J]. 介入放射学杂志, 2011, 20: 448- 451.
[5] Zhang L, Fan WJ, Huang JH, et al. CT guided 125I seeds implantation in treatment of local recurrent rectal cancer after surgery resection: analysis of 21 cases[J]. Zhonghua Yi Xue Za Zhi, 2008, 88:1335- 1338.
[6] Bittner N, Merrick GS, Butler WM, et al. Long- term outcome for very high- risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy[J]. Brachytherapy, 2012, 11: 250- 255.
[7] Podgorsak EB. Radiation oncology physics: a handbook for teachers and students[J]. Br J Cancer, 2008, 98: 1020.
[8] Jiang YL, Meng N, Wang JJ, et al. Percutaneous computed tomography/ultrasonography- guided permanent iodine- 125 implan-tation as salvage therapy for recurrent squamous cell cancers of head and neck[J]. Cancer Biol Ther, 2010, 9: 959- 966.
[9] Lee W, Daly BD, Dipetrillo TA, et al. Limited resection for non- small cell lung cancer: observed local control with implantation of 125I brachytherapy seeds[J]. Ann Thorac Surg, 2003, 75: 237- 242.
[10] Jin Z, Du Y, Li Z, et al. Endoscopic ultrasonography- guided interstitial implantation of Iodine 125- seeds combined with chemo- therapy in the treatment of unresectable pancreatic carci-noma: a prospective pilot study[J]. Endoscopy, 2008, 40: 314- 320.
[11] 王 娟, 吴 娟, 魏 东, 等. CT引导下125I粒子植入治疗腹膜后淋巴结转移癌18例的初步疗效[J]. 介入放射学杂志, 2015, 24: 219- 222.
[12] Beaulieu L, Archambault L, Aubin S, et al. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs[J]. Int J Radiat Oncol Biol Phys, 2004, 58: 1298- 1308.
[13] Bues M, Holupka EJ, Meskell P, et al. Effect of random seed placement error in permanent transperineal prostate seed implant[J]. Radiother Oncol, 2006, 79: 70- 74.
[14] 王 娟, 王绍其, 徐建彬, 等. 125I粒子不同分布组织间植入对荷人胃癌裸鼠移植瘤疗效的影响[J]. 中华核医学杂志, 2008, 28: 313- 316.
[15] Wuu CS, Ennis RD, Schiff PB, et al. Dosimetric and volumetric criteria for selecting a source activity and a source type(125I or 103Pd) in the presence of irregular seed placement in permanent prostate implants[J]. Int J Radiat Oncol Biol Phys, 2000, 47: 815- 820.
相似文献/References:
[1]何 闯,刘 云*,杨 丽,等.CT引导下125I粒子植入治疗腹膜后淋巴结转移瘤[J].介入放射学杂志,2014,(11):1022.
HE Chuang,LIU Yun,YANG Li,et al.CT guided radioactive 125I seed implantation therapy for retroperitoneal lymph node metastasis[J].journal interventional radiology,2014,(03):1022.
[2]何 闯,刘 云,杨 丽,等.CT引导下125I粒子治疗腹膜后淋巴结转移瘤植入技巧[J].介入放射学杂志,2015,(06):534.
HE Chuang,LIU Yun,YANG Li,et al.CT- guided 125I seed implantation for retroperitoneal lymph node metastases: its technical points[J].journal interventional radiology,2015,(03):534.